Molecular analysis of OXA-48-producing Escherichia coli in Switzerland from 2019 to 2020.
Options
BORIS DOI
Date of Publication
November 2022
Publication Type
Article
Division/Institute
Contributor
Findlay, Jacqueline | |
Poirel, Laurent | |
Nordmann, Patrice |
Series
European journal of clinical microbiology & infectious diseases
ISSN or ISBN (if monograph)
0934-9723
Publisher
Springer
Language
English
Publisher DOI
PubMed ID
36103096
Uncontrolled Keywords
Description
OXA-48-type ß-lactamases are the most prevalent carbapenemase-type in Enterobacterales in Switzerland, predominantly found in Escherichia coli and Klebsiella pneumoniae. Bacteria-producing OXA-48-type enzymes are endemic in some parts of the world, including Europe and North Africa, and are a frequent cause of nosocomial infections. Despite the emergence of numerous OXA-48-type variants, the original variant, OXA-48, remains the most prevalent in E. coli. This study describes the epidemiology of OXA-48-producing E. coli isolates submitted to the Swiss National Reference Center for Emerging Antibiotic Resistance (NARA) between January 2019 and December 2020.
File(s)
File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
---|---|---|---|---|---|---|---|
s10096-022-04493-6.pdf | text | Adobe PDF | 1.11 MB | published |